Skip to ContentSkip to Navigation
About us Latest news News News articles

Cognitive dysfunction in bipolar disorder: between determinants and consequences

11 April 2012

PhD ceremony: Ms. M.J. van der Werf-Eldering, 12.45 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Cognitive dysfunction in bipolar disorder: between determinants and consequences

Promotor(s): prof. W.A. Nolen, prof. A. Aleman

Faculty: Medical Sciences

Patients known with bipolar disorder can show cognitive dysfunction when experiencing mood symptoms, but also in absence of these symptoms (euthymic phase). This thesis gives an overview of the type and extent of cognitive dysfunction, the clinical relevant factors and the relationship with functional outcome. Cognitive dysfunction, especially in areas of speed and attention, is related to depressive symptoms, worse illness course, and worse occupational as well as psychosocial outcome. Changes in the stress system (HPA-axis) are related to both depression and cognitive dysfunction and could therefore play a role in the presence of cognitive disturbances in bipolar patients. However, we could not confirm the hypothesis that changes in the HPA-axis can explain the associations between depressive symptoms and cognition in bipolar patients. It is important to know a patients personal opinion about his own cognitive performance and the ability to evaluate his personal condition (the level of illness-insight). In bipolar patients complaints about cognitive dysfunction was not associated with objective cognitive dysfunction, however complaining was related to depressive symptoms. Moreover, cognitive functioning – besides emotional learning and the presence of lifetime psychotic features – contributed to better illness insight. In conclusion, besides striving for stabilizing mood symptoms, treatment of bipolar patients needs to take into account the possible presence of cognitive dysfunction. There is a need for (international) consensus about the optimal cognitive test battery, the interpretation of the test results, and how to proceed in case objective cognitive dysfunction is found.

Last modified:13 March 2020 12.59 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.